Citadel Advisors - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$1,769,551
-62.1%
82,343
-57.7%
0.00%
-100.0%
Q1 2023$4,672,364
+46.2%
194,763
+41.4%
0.00%0.0%
Q4 2022$3,195,150
+61.8%
137,722
+11.7%
0.00%
Q3 2022$1,975,000
-37.7%
123,289
-31.1%
0.00%
-100.0%
Q2 2022$3,170,000
+11.7%
178,907
+28.4%
0.00%
Q1 2022$2,837,000
+499.8%
139,325
+482.1%
0.00%
Q3 2021$473,000
-3.3%
23,933
+15.8%
0.00%
Q2 2021$489,000
-73.3%
20,672
-73.3%
0.00%
Q1 2021$1,834,000
-37.7%
77,357
-47.4%
0.00%
-100.0%
Q4 2020$2,946,000
+89.3%
147,066
+96.8%
0.00%
Q3 2020$1,556,000
+95.5%
74,742
+64.5%
0.00%
Q2 2020$796,000
-69.2%
45,446
-71.3%
0.00%
-100.0%
Q1 2020$2,583,000
+1966.4%
158,165
+1354.7%
0.00%
Q3 2019$125,000
-72.1%
10,873
-68.1%
0.00%
Q2 2019$448,000
-81.4%
34,103
-78.5%
0.00%
-100.0%
Q1 2019$2,407,000
+28.2%
158,987
+45.4%
0.00%0.0%
Q4 2018$1,877,000
-46.2%
109,319
-53.8%
0.00%0.0%
Q3 2018$3,488,000
+207.0%
236,556
+396.4%
0.00%
Q2 2018$1,136,000
-87.9%
47,659
-87.1%
0.00%
-100.0%
Q1 2018$9,417,000
-40.7%
368,609
-57.2%
0.01%
-50.0%
Q4 2017$15,889,000
+178.4%
860,727
+58.2%
0.01%
+150.0%
Q3 2017$5,707,000
+632.6%
544,033
+773.8%
0.00%
+300.0%
Q2 2017$779,000
-3.6%
62,262
-22.5%
0.00%0.0%
Q1 2017$808,00080,3090.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
Rubric Capital Management LP 1,926,283$40,105,0003.74%
Camber Capital Management LP 4,000,000$83,280,0002.20%
FRAZIER MANAGEMENT LLC 943,666$19,647,0001.76%
MANGROVE PARTNERS IM, LLC 593,741$12,362,0001.56%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 303,685$6,323,0001.07%
Eventide Asset Management 2,427,976$50,550,0000.99%
Avidity Partners Management LP 1,000,400$20,828,0000.97%
RICE HALL JAMES & ASSOCIATES, LLC 1,108,219$23,073,0000.93%
Perceptive Advisors 2,058,068$42,849,0000.63%
Rock Springs Capital Management LP 1,175,000$24,464,0000.62%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders